Coherus Oncology (CHRS) Stock Price & Financial Analysis
Coherus Oncology Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Coherus Oncology
What is the current stock price for CHRS?
As of the latest trading session, CHRS stock trades at $1.51. The 52-week range is $0.71–$2.62, with a day range of $1.47–$1.56.
What is the P/E ratio for CHRS?
Coherus Oncology's trailing P/E ratio is 1.1, meaning investors pay $1.1 for every $1 of annual earnings. The forward P/E is 0.6, reflecting analyst expectations for future earnings.
Does CHRS pay dividends?
Coherus Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CHRS?
Analyst ratings and recommendations for CHRS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CHRS?
Coherus Oncology's market capitalization is $181.8M, classifying it as a micro-cap company..